drugset / Trial / NCT04169464
The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this study is to investigate the occurrence of AKI during antiviral therapy, when compared with baseline values in Egyptian patients. In addition, the study aims to evaluate the change in insulin resistance value after treating patients from HCV.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2019-11
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sofosbuvir | Small molecule | — | Oral |
Indications
No indication recorded.